Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,241.64
(
0.45%
)
US TECH 100
26,943.60
(
0.88%
)
Dow Jones
49,656.54
(
0.01%
)
Brent Oil
107.63
(
-2.46%
)
Bitcoin
78,175.24
(
2.42%
)
News Focus
News Focus

Replies to post #57894 on $heff's $tation of $tocks & $olid DD

Replies to #57894 on $heff's $tation of $tocks & $olid DD
icon url

$heff

08/14/12 1:06 PM

#57985 RE: $heff #57894

$4.36..EXEL Phase 3 cabozantinib PDUFA is 11/29/2012 under PR for Medullary Thyroid Cancer. Ad Com meeting scheduled for 11/6-7/2012.